customer news Arna Ionescu Stoll customer news Arna Ionescu Stoll

Tetraphase Pharmaceuticals selects R&D Logic software.

December 2013 — Tetraphase Pharmaceuticals, located in Watertown, Massachusetts has selected R&D Logic software and services to automate FP&A processes: planning, tracking, analysis and reporting. Tetraphase is a clinical-stage biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics for serious and life-threatening multi-drug resistant (MDR) infections.

Read More
customer news Arna Ionescu Stoll customer news Arna Ionescu Stoll

Sarepta Therapeutics selects R&D Logic software.

December 2013 — Sarepta Therapeutics, located in Cambridge, Massachusetts has selected R&D Logic software and services to manage corporate planning, tracking, analysis and reporting. Sarepta Therapeutics is focused on developing first-in-class RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases.

Read More
customer news Arna Ionescu Stoll customer news Arna Ionescu Stoll

Enanta Pharmaceuticals selects R&D Logic platform software.

March 2013 — Enanta Pharmaceuticals, located in Watertown, Massachusetts has subscribed to R&D Logic software and services to manage corporate planning, tracking, reporting as well as time collection processes. Enanta is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field.

Read More
customer news Arna Ionescu Stoll customer news Arna Ionescu Stoll

BIND Biosciences selects R&D Logic's Time Collection software.

January 2013 — BIND Biosciences, located in Cambridge, Massachusetts has subscribed to R&D Logic software and services for collecting, managing and reporting collaborator project time, project FTEs as well as time off. BIND is a clinical-stage biopharmaceutical company developing a new class of highly selective targeted therapeutics called Accurins.

Read More